Literature DB >> 7395932

The conservative aggressive management of placenta previa.

D B Cotton, J A Read, R H Paul, E J Quilligan.   

Abstract

One hundred and seventy-three cases of placenta previa managed at the Women's Hospital of Los Angeles County-University of Southern California Medical Center from July, 1975, through June, 1978, were reviewed and compared to a similar series of cases studied in the same institution in 1969. The perinatal mortality of 12.6% was roughly one half of that in the earlier study. The fetal death rate did not change significantly, but the neonatal mortality was markedly less, especially in the 27-to-32-week range. Expectant management was employed in 65.8% of patients, as compared to 42.6% in 1969. The higher rate of expectant management was characterized by the aggressive use of antepartum transfusions in the face of moderate-to-severe bleeding in lieu of delivery, as well as the occasional use of tocolytic agents for inhibition of premature labor in the presence of vaginal bleeding. Elective termination of pregnancy utilizing the lecithin/sphingomyelin (L/S) ratio for determination of pulmonary maturation also resulted in significantly less overall neonatal morbidity and mortality. These multiple factors appear to have contributed to a dramatic reduction in the perinatal mortality associated with placenta previa.

Entities:  

Mesh:

Year:  1980        PMID: 7395932     DOI: 10.1016/s0002-9378(15)33242-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Risk Factors and Pregnancy Outcomes: Complete versus Incomplete Placenta Previa in Mid-pregnancy.

Authors:  Yun Feng; Xue-Yin Li; Juan Xiao; Wei Li; Jing Liu; Xue Zeng; Xi Chen; Kai-Yue Chen; Lei Fan; Qing-Ling Kang; Su-Hua Chen
Journal:  Curr Med Sci       Date:  2018-08-20

2.  Using tocolysis in pregnant women with symptomatic placenta praevia does not significantly improve prenatal, perinatal, neonatal and maternal outcomes: a systematic review and meta-analysis.

Authors:  Frederick Morfaw; Mercy Fundoh; Jessica Bartoszko; Lawrence Mbuagbaw; Lehana Thabane
Journal:  Syst Rev       Date:  2018-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.